AU5623398A - Methods of therapeutic administration of anti-cd40l compounds - Google Patents

Methods of therapeutic administration of anti-cd40l compounds

Info

Publication number: AU5623398A
Authority: AU; Australia
Prior art keywords: methods; therapeutic administration; cd40l compounds; cd40l; compounds
Prior art date: 1997-03-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU56233/98A

Inventor

Susan L. Kalled

David W Thomas

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Biogen Inc

Original Assignee

Biogen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-07

Filing date

1997-12-31

Publication date

1998-09-22

1997-12-31 Application filed by Biogen Inc filed Critical Biogen Inc

1998-09-22 Publication of AU5623398A publication Critical patent/AU5623398A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Life Sciences & Earth Sciences (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU56233/98A 1997-03-07 1997-12-31 Methods of therapeutic administration of anti-cd40l compounds Abandoned AU5623398A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US4015497P	1997-03-07	1997-03-07
US60040154		1997-03-07
PCT/US1997/024133 WO1998039026A2 (en)	1997-03-07	1997-12-31	Methods of therapeutic administration of anti-cd40l compounds

Publications (1)

Publication Number	Publication Date
AU5623398A true AU5623398A (en)	1998-09-22

Family

ID=21909414

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU56233/98A Abandoned AU5623398A (en)	1997-03-07	1997-12-31	Methods of therapeutic administration of anti-cd40l compounds

Country Status (3)

Country	Link
AU (1)	AU5623398A (en)
HU (1)	HUP0001263A3 (en)
WO (1)	WO1998039026A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL104684A0 (en)	1992-02-14	1993-06-10	Bristol Myers Squibb Co	The cd40cr receptor and ligands therefor
KR20010072564A (en) *	1998-04-03	2001-07-31	존 에프. 카바나프	USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE
EP1101495A4 (en) *	1999-06-01	2003-05-07	Eisai Co Ltd	Preventives for idiopathic thrombocytopenic purpura
EP1839674A1 (en) *	1999-10-04	2007-10-03	Novartis Vaccines and Diagnostics, Inc.	CD40 antagonist for treating psoriasis
ATE363290T1 (en) *	1999-10-04	2007-06-15	Novartis Vaccines & Diagnostic	CD40 ANTAGONIST FOR THE TREATMENT OF PSORIASIS
IL149500A0 (en) *	1999-11-08	2002-11-10	Idec Pharma Corp	Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy
EP1262194A4 (en) *	2000-03-06	2003-05-07	Eisai Co Ltd	Remedies and preventives for antiphospholipid antibody syndrome
AU2001251612A1 (en)	2000-04-14	2001-10-30	Millennium Pharmaceuticals, Inc.	Roles of jak/stat family members in tolerance induction
BR0111158A (en)	2000-05-12	2004-04-06	Genzyme Corp	Compound and physiological salts thereof, method for treating a median condition by tnf-a in a patient
WO2001087310A1 (en) *	2000-05-18	2001-11-22	Biotransplant, Inc.	Process for reducing antibody response against xenografts
AU8867501A (en) *	2000-09-01	2002-03-13	Biogen Inc	Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
MXPA03002262A (en) *	2000-09-18	2003-10-15	Idec Pharma Corp	Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination.
ES2363914T3 (en)	2002-11-21	2011-08-19	Genzyme Corporation	USE OF A DIAMIDE DERIVATIVE TO INHIBIT THE CHRONIC REJECTION OF A TRANSPLANT.
AU2003291143A1 (en)	2002-11-21	2004-06-18	Genzyme Corporation	Combination of diamide derivatives and immunosuppressive agents for induction of immune tolerance
WO2025117849A1 (en)	2023-11-28	2025-06-05	Eledon Pharmaceuticals, Inc.	Methods and compositions for prevention of transplant rejection

1997
- 1997-12-31 AU AU56233/98A patent/AU5623398A/en not_active Abandoned
- 1997-12-31 WO PCT/US1997/024133 patent/WO1998039026A2/en not_active Ceased
1998
- 1998-01-09 HU HU0001263A patent/HUP0001263A3/en unknown

Also Published As

Publication number	Publication date
HUP0001263A3 (en)	2005-11-28
HUP0001263A2 (en)	2000-08-28
WO1998039026A2 (en)	1998-09-11

Similar Documents

Publication	Publication Date	Title
AU6491196A (en)	1997-02-18	Epidural administration of therapeutic compounds with sustained rate of release
AU6094996A (en)	1996-12-30	Diphosphonate derivatives of therapeutic agents
AU2805195A (en)	1996-02-09	Therapeutic compounds
AU1041599A (en)	1999-06-07	Therapeutic uses of triazolo-pyridazine derivatives
AU8676698A (en)	1999-02-22	Devices for providing therapeutic substances
AU5623398A (en)	1998-09-22	Methods of therapeutic administration of anti-cd40l compounds
AU2939897A (en)	1997-12-05	Administration of histamine for therapeutic purposes
PL327732A1 (en)	1998-12-21	Compounds of therapeutic activity
GB9601186D0 (en)	1996-03-20	Administration of Drugs
AU6450398A (en)	1998-09-22	Sr-bi regulatory sequences and therapeutic methods of use
AU6821196A (en)	1997-03-12	Transdermal administration of vorozole
HUP9901438A3 (en)	2000-07-28	Therapeutic pyrimidine compounds
AU8817398A (en)	1999-03-08	Method of drug selection
AU6171196A (en)	1996-12-30	Therapeutic uses of ta99
AU5330198A (en)	1998-07-17	Therapeutic compounds
AU4596097A (en)	1998-04-17	Improved therapeutic uses of 4-quinoline-carboxylic acid derivatives
AU1828399A (en)	1999-07-12	Novel formulations for the transdermal administration of asimadoline
AU4491697A (en)	1998-04-17	Compositions of therapeutic agents suitable for oral administration
AUPO480997A0 (en)	1997-02-20	Therapeutic compounds
AUPO572197A0 (en)	1997-04-10	Therapeutic compounds
AUPO481197A0 (en)	1997-02-20	Therapeutic compounds
AUPO624897A0 (en)	1997-05-15	Therapeutic compounds
AUPN228095A0 (en)	1995-05-04	Therapeutic compounds
HK1014961A (en)	1999-10-08	Therapeutic compounds
AUPN090295A0 (en)	1995-03-02	Therapeutic compounds